Explore by Category
Blood Type and Multiple Myeloma Outcomes
LIFE WITH MYELOMA - January 13, 2021
Does blood type matter when it comes to multiple myeloma? Turkish researchers shared new data in the Magazine of European Medical Oncology showing tha... Read More
Pesticide Use Linked to Myeloma Precursor Conditions
LIFE WITH MYELOMA - January 12, 2021
A recent study of male farmers shows that the use of certain types of pesticides are associated with the precursor condition of multiple myeloma called&nbs... Read More
Underweight or Overweight: Myeloma Patients Have the Best Outcomes with Stable, Healthy Weight
LIFE WITH MYELOMA - January 07, 2021
When I was diagnosed with multiple myeloma, it was preceded over several years by a 15 pound weight loss. I thought my body was ready to get back to m... Read More
Top 10 Reasons To Get Involved In The Myeloma Crowd Community in 2021
LIFE WITH MYELOMA - December 31, 2020
10. Learn Educated and empowered myeloma patients live longer. Rather than searching the internet, learn directly from myeloma specialists. Over 75 exp... Read More
Reasons to Relax: How Stress Hormones can Trigger Cancer Regrowth
LIFE WITH MYELOMA - December 30, 2020
We know that myeloma goes away but that it most often returns out of remission. Myeloma experts hypothesize that the treatment kill some but not all of the myel... Read More
What Myeloma Patients Receiving COVID Vaccinations Need to Know
LIFE WITH MYELOMA - December 20, 2020
A friend recently asked if monoclonal antibody therapy such as daratumumab would have a deleterious effect on receiving a COVID vaccination. Would he stil... Read More
ASH 2020: MGUS in Black Multiple Myeloma Patients
LIFE WITH MYELOMA - December 09, 2020
What risk factors affect the progression of MGUS to active myeloma in the African American population? Kimberly A. Bertrand, ScD from Boston University con... Read More
ASH 2020: A Myeloma Coach's Perspective on Accelerating the Standard of Care
LIFE WITH MYELOMA - December 08, 2020
The scientific excitement emerging from ASH 2020 is significant and for good reason! Thanks go out to the scientists, clinical trial participants and clinicians... Read More
ASH 2020: Managing CAR T Side Effects in Multiple Myeloma
LIFE WITH MYELOMA - December 05, 2020
CAR T therapy side effects are potentially consequential for multiple myeloma patients, but myeloma experts are now more experienced at managing them well, acco... Read More
ASH 2020: Turning Hope into Reality - What to Know and What to Do!
LIFE WITH MYELOMA - December 05, 2020
The American Society of Hematology Annual Meeting is off to a great start! Although the meeting is virtual, the web-based technology is working well, and this y... Read More
ASH 2020: Real World Use of Minimal Residual Disease (MRD) Testing in Multiple Myeloma
LIFE WITH MYELOMA - December 04, 2020
How important is MRD testing for myeloma patients and what are the practical implications of using it in clinical trials as an earlier end-point? This is the qu... Read More
ASH 2020: Myeloma and The Microbiome - The Proven Connection
LIFE WITH MYELOMA - December 04, 2020
At the American Society of Hematology (ASH) 2020 Thursday scientific workshop, Dr. Leif Bergsagel of the Mayo Clinic gave a short presentati... Read More
COVID-19 Isolation Precautions for Immunocompromised Patients
LIFE WITH MYELOMA - December 03, 2020
The Center of Disease Control (CDC) has modified Covid-19 quarantine recommendations on December 2nd, 2020. The updated recommendations can be summarized as fol... Read More
